Eurofins Scientific (Paris: ERF) repurchased a total of 85,000 of its own shares between July 20 and July 24, 2026, at a weighted average price of €68.33 per share, according to a regulatory disclosure.

The buybacks were executed across two markets: Euronext Paris (XPAR) and the Cboe Europe exchange (CEUX). Daily transaction volumes ranged from 8,000 to 35,000 shares, with weighted average daily prices ranging from approximately €66.12 to €70.83.

The transactions are reported in compliance with Article 5(1)(b) of EU Market Abuse Regulation No. 596/2014.